Fans of wearable devices in more countries might start considering using the Samsung Galaxy Watch 3 or Watch Active 2 as their vital health monitoring features will be available soon. The tech company acquired the necessary permissions for its Health Monitor app to function in a total of 31 countries.
Samsung’s advanced health monitoring services cleared for use in more countries
The Samsung Galaxy Watch 3 and Watch Active 2 are equipped with sensors that allow them to monitor a user’s blood pressure and function with electrocardiogram (ECG) tracking. However, reading this data would require the Samsung Health Monitor app.
Like other health and medical products, the Samsung Health Monitor app needed to be approved in different countries following different regulations. It explains why tech features of this nature typically launch in limited territories. However, this changes for Samsung after the company acquired CE-marking last December for the software product allowing it to launch in European countries.
Samsung Galaxy Watch 3 and Watch Active 2 users Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom will soon be able to use the said app for BP and ECG tracking. The app is also launching in Chile, Indonesia, and the UAE making it available in 31 countries after only being accessible in South Korea.
Once the Samsung Health Monitor app goes live in the said countries, Samsung Galaxy Watch 3 and Watch Active 2 have to be updated to their latest versions. Doing so will automatically install the app on the wearable devices. Updates can be initiated through the Galaxy Wearable app via a paired Galaxy smartphone.
Samsung Galaxy Watch 4 rumored to launch with blood sugar level sensor
Having a blood pressure and ECG monitor on people’s wrists through devices like Samsung Galaxy Watch 3 and Watch Active 2 is already a notable technological development. But the company is reportedly looking to add another essential medical tracker in its upcoming Galaxy Watch 4.
ET News reported that Samsung is planning to launch the Galaxy Watch 4 with blood sugar level tracking this year. It is expected to use optic sensors that would allow measure blood glucose levels without blood sampling.


SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure 



